Amneal Pharmaceuticals Inc Class A (AMRX)

Depreciation & Amortization

$194.29M

TTM · Period ending: · USD

AMRX logo

AMRX Depreciation & Amortization

Latest reported$194.29M
AMRX TTM Depreciation & Amortization ($45.94M → $194.29M)
High-resolution chart · PNG

AMRX depreciation & amortization history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Amneal Pharmaceuticals Inc Class A Depreciation & Amortization — Trailing twelve months (TTM) (USD)
Period endingDepreciation & Amortization (USD)
194,291,000
206,604,000
223,572,000
240,475,000
245,363,000
240,822,000
236,191,000
226,994,000
225,239,000
226,778,000
229,400,000
233,523,000
237,925,000
240,510,000
240,175,000
240,302,000
238,880,000
235,672,000
233,406,000
232,096,000
231,269,000
232,853,000
235,387,000
229,817,000
223,816,000
216,450,000
207,235,000
200,425,000
190,080,000
171,520,000
137,403,000
102,752,000
71,697,000
50,087,000
45,936,000
42,808,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.